March 20, 2008
NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
March 17, 2008
NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
March 11, 2008
NanoBio Founder Named 2008 Distinguished University Innovator
March 06, 2008
NanoBio Corporation Completes $30 Million Funding by Meeting Key Development Milestones
February 26, 2008
Nasal Vaccine for Smallpox Confers High Levels of Immunity without Safety Risks
February 1, 2008
NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
January 30, 2008
New Patent Awarded for Vaccine Adjuvant Technology that Elicits Robust Immunity
January 15, 2008
Stephen Gracon, D.V.M., Joins the NanoBio Team as VP of Regulatory Affairs
October 30, 2007
Joyce Sutcliffe, PhD, Joins the NanoBio Team as Vice President of Research
October 5, 2007
NanoBio Wins 2007 Michigan Innovation Award
September 25, 2007
NanoBio Expands Drug Development Team for its Anti-Infective Products
September 19, 2007
New Topical Therapy Safely Treats Serious Skin Infections without Systemic Side Effects
August 16, 2007
Easy-to-use nasal anthrax vaccine offers strong protection in animal studies
July 17, 2007
Jerald C. Sadoff, MD Joins NanoBio Scientific Advisory Board
July 10, 2007
NanoBio® Corporation Receives $2.4M Award From Michigan's 21st Century Jobs Fund
May 22, 2007
NanoBio® Corporation Announces Positive Phase 1
Clinical Results for Topical Treatment for Onychomycosis
April 3, 2007
NanoBio Corporation Initiates Phase 2 Clinical Trial for the treatment of Onychomycosis
February 15, 2007
NanoBio Corporation Initiates Phase 2b Clinical Trial for Herpes Labialis Treatment
October 11, 2006
NanoBio Corporation Announces Appointment of Dr. Ronald Cresswell to Board of Directors
September 27, 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
August 7, 2006
NanoBio Secures $30 Million Private Equity Financing
February 9, 2006
David Peralta Joins NanoBio as CFO
July 11, 2005
$6.3M Gates Foundation Grant Secured for Development of a NanoStat™ Based Mucosal Vaccine
June 17, 2004
Jay Birnbaum, Ph.D., Joins Science Advisory Board
January 29, 2004
Three New Patents Awarded
December 16, 2003
Dept. of Defense Awards NanoBio $3.2 Million Contract
|
